Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03632941
Title A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Herbert Lyerly
Indications

breast cancer

Therapies

Pembrolizumab

AVX901 + Pembrolizumab

AVX901

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.